Anthony Albanese says Labor will fight ‘frustration' in government and deliver on election promises, in National Press Club address
The Prime Minister will put forward his second-term agenda in an address to the National Press Club in Canberra on Tuesday, vowing to 'make a real difference to people's lives'.
That includes delivering on Labor's policies to boost bulk-billed GP appointments, decrease student debt and other cost-of-living measures.
While he will acknowledge the 'significant global uncertainty' and 'economic instability' currently underpinning the world, he says Labor will be a 'practical and positive alternative' and delivers on its 'vision for a stronger, fairer Australia'.
'It is the more corrosive proposition that politics and government and democratic institutions, including a free media, are incapable of meeting the demands of this moment,' he is expected to say.
'Our responsibility is to disprove it.
'To recognise that some of this frustration is drawn from people's real experience with government – be it failures of service delivery, or falling through the cracks of a particular system.
'To counter this, we have to offer the practical and positive alternative.'
Mr Albanese's comments on a volatile international environment comes as he is expected to have his first face-to-face meeting with US President Donald Trump when he travels to Canada for the G7 Leader's Summit over the weekend.
Labor faces a heavy policy agenda when parliament finally sits on July 22 for the first time since the May 3 election, with Mr Albanese promising to legislate a 20 per cent discount of student debts as its first priority.
Mr Albanese will also highlight Labor's election vow to ensure 90 per cent of GP visits are bulk-billed by 2030, progress on reaching net zero emissions by 2050, and its continued target to build 1.2 million new homes through the Housing Accords as other key areas for 'delivery' in Labor's second term.
'Our second term agenda has been shaped by the lives and priorities of the Australian people. And it is built on Australian values,' he will say.
'It is the mission and the measure of a Labor government to give those enduring ideals of fairness, aspiration and opportunity renewed and deeper meaning, for more Australians.
'To deliver reforms that hold no-one back – and drive progress that leaves no-one behind.'
The government will also expand its First Home Guarantee scheme to all first home buyers, regardless of income caps, which allow them to purchase an eligible property with a 5 per cent deposit, while also avoiding lender's mortgage insurance.
Labor has also committed to investing $10bn to build 100,000 new homes which will be earmarked for firsthome buyers.
Since Labor's election landslide on May 3, it has faced attacks on its plan to bring in a 30 per cent tax on superannuation balances over $3m.
While the Greens have already flagged it will work with Labor to most likely pass the tax in the Senate, the Coalition have criticised the policy as a 'grab for revenue'.
However Jim Chalmers has rebuked changes to the tax, calling the changes 'modest' and 'methodical,' which will make a 'meaningful difference to the budget'.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Sky News AU
15 minutes ago
- Sky News AU
Malcom Turnbull told to stop AUKUS meddling
Former prime minister Malcom Turnbull has been told to stop meddling in the AUKUS review as it has been revealed he has had several conversations with the man reviewing the alliance. Mr Turnbull has long been a critic of AUKUS and has not been shy about vocalising it. The US is undertaking a review of AUKUS, the alliance between the US, Australia, and the UK, over nuclear-powered submarines. The US review was supposed to be wrapped up by the end of June, but the Albanese government has advised it has been extended.
7NEWS
18 minutes ago
- 7NEWS
Adam Schwab: Aussie CEO says working from home is the ‘worst thing ever'
The CEO of a luxury travel company has hit out against employees who want to work from home, telling them to move to 'somewhere that does that'. Adam Schwab, Luxury Escapes chief executive, said his workers are expected to be in office for the entire five day working week. He told the Herald Sun that working from home is 'the worst thing ever', and that it is hard to 'progress your career if you can't learn from other people'. Mr Schwab went on to claim that work promotions are often based on 'who's in your proximity'. 'It's hard to progress your career if you can't learn from other people. If people can't see you. Unfortunately, getting promoted is often based on just who's in your proximity,' he said. He says flexible working arrangements can be available when needed, but that employees must always provide a reason. 'Obviously, if someone has a real need we'll work around that.' Luxury Escapes was founded in 2013 by both Mr Schwab and his friend from school, Jeremy Sane. The company has grown from a small Australian based team, to a now global company with more than 600 employees. Mr Schwab said Luxury Escapes' employee retention rate is very high, with less than 10 per cent leaving the company each year. The CEO said this is a good number and that percentage of people leaving represents those who get a different job or are retiring. He said he believes in collaboration, and told employees that would rather work from home to instead find another job, claiming Luxury Escapes is 'not for (them)'. Luxury Escapes now has offices in Melbourne, Sydney, London, Barcelona and Singapore. Mr Schwab began his professional career as a lawyer. 'I thought I really wanted to be a lawyer. And then you do it and you realise it's really not good. It's pretty boring. It's really long hours. I was an okay lawyer … but (there were) people who were really, really good lawyers. I wasn't ever going to be that.' Both Mr Schawb and Mr Sane decided to leave their corporate jobs behind and started a short term accommodation business in Melbourne. They then created Luxury Escapes after deciding to work in the travel business, and the company now has more than eight million members.
News.com.au
41 minutes ago
- News.com.au
Biocurious: with fresh grant funding, Emvision's Emu stroke device won't take a step backwards
A fresh $5 million government grant takes Emvision's cumulative non-dilutive funding to $25 million The company is trialing its Emu stroke detection device with a view to FDA clearance The lightweight variant First Responder could give ambulances rapid stoke detection capabilities With US biotech grant funding under pressure, drug and device developers need to delve more deeply for sources of valuable non-dilutive capital. Happily, numerous programs are still available for Australian life sciences plays willing to do their homework. In the case of stroke and traumatic brain injury (TBI) detection device developer Emvision, grant funding and partnerships have underpinned the company since it was formed in 2017. Co-founder and CEO Scott Kirkland puts the running tally at $25 million. This month, Emvision was awarded a $5 million Australian Government Industry Growth Program Commercialisation and Growth Grant. The funding is to accelerate development of Emvision's portable brain scanner, First Responder. Other funding sources have included the Australian Stroke Alliance, the NSW Medical Devices Fund and – we kid you not – the Modern Manufacturing Medical Products Manufacturing Translation Stream Project. Take nothing for grant-ed Kirkland says applying for grants takes significant time and management focus – and companies usually need to kiss a lot of frogs. 'You really need to dig around on the guidelines and look at what they have funded previously,' he says. 'But there are plenty of opportunities where objectives are boosting domestic manufacturing, creating engineering roles, generating IP and tackling the big health and societal burdens.' In the case of the US, the military complex can fund programs of specific interest, such as TBI assessment. The company is likely to progress TBI – a 'significant unmet need' – via a collaboration or grant. The Golden Hour As far as 'big health societal burdens' go, Emvision is tackling the need for more portable – and thus faster – ways to detect a stroke. The first 60 minutes post-event is known as the Golden Hour. But even the second hour – dubbed, you guessed it, the Silver Hour – is vital. 'With a stroke, time is brain,' Kirkland says. 'The faster it is diagnosed and treated; the more of the brain function that can be saved'. If treated early, a clot is softer and more treatable via clot-busting drugs or surgical removal of the blockage. In the US, a study of Mobile Stroke Units (MSUs) with a CT (computed tomography) scanner reported 33% of patients being treated in the first hour. This compared to just 3% for the normal ambulance arm. 'If you can bring the diagnostics tools to the patients, you save a lot of time to achieve better functional outcomes and less disability,' Kirkland says. Different strokes for different folks Clinicians and paramedics need to know whether the stroke is a blockage (ischaemic) or a bleed (haemorrhagic) as different treatments apply. To date, patients have been imaged with bulky, centralised scanners in hospitals. Emvision is developing a portable bedside scanner – Emu – which can be moved bed to bed on a cart. These units weigh about 100 kilograms, compared with a few tonnes for a typical CT unit. A trained healthcare professional can operate Emu, whilst a CT requires a radiographer. In a regular neurological intensive care unit, Emu's ability to hop from bed to bed is better than carting fragile patients to radiology. Emvision hopes Emu will pave the regulatory pathway for First Responder, its backpack-sized version for use in road and air ambulances and remote locations. On trial Emvision's work currently revolves around a pivotal trial for Emu, to support US Food & Drug Administration (FDA) clearance under the De Novo (novel device) pathway. The company hopes this will pave the way for First Responder approval under the less arduous 510(k) predicate device route. The US trial sites consist of New York's Mt Sinai, Florida's Mayo Clinic and Houston's Memorial Hermann Texas Medical Centre. A west coast site is pending. Locally, the trial has enlisted the Royal Melbourne Hospital and Sydney's Liverpool Hospital. They are all high calibre research centres handling high stroke volumes. The study aims to enrol up to 300 suspected stroke victims, who will receive the usual clinical care along with an Emu scan. Overlaying that, Emu then determines whether the stroke is a bleed or not, with a primary endpoint of at least 80% sensitivity and specificity for haemorrhage detection. Sensitivity is the ability to detect positive results, while specificity is the ability to discount false positives. The patients might have a different 'stroke mimic' condition, such as a migraine or epileptic seizure. 'We are seeking to also demonstrate that a 'mimic' does not confound our algorithms,' Kirkland says. Never a step back with Emu In an earlier domestic trial called Emview, Emu achieved 92% sensitivity and 85% specificity for bleed detection in a smaller cohort. For blockages, the results showed 95% sensitivity and 85% specificity. Kirkland says CT is good for detecting bleeds, with a 90-99% sensitivity. Without the use of contrast agents, it's less so for blockages (30-70%). (About 80% of stroke cases are blockages). Kirkland says while CT (or MRI) scans provide the 'ground truths', Emu's performance doesn't need to be identical to these machines. Especially in the case of First Responder, operators will use them where traditional neuroimaging is unavailable. Eyeing the US market While strokes afflict 15 million people annually – one-third fatally – there are fewer than 50 dedicated Mobile Stroke Unit ambulances globally. (Melbourne hosts two of them). That's because they cost upwards of $1 million to set up and a similar amount to operate annually. First Responder could provide every ambulance with a stroke and stroke type detection function. The US market eclipses anywhere else: 60,000 road ambulances – half the global tally – and 1500-1800 air ambulances. Post approval, Emvision's initial focus is likely to be in the expanded 'stroke belt' of southern states including Texas and Florida. For lifestyle and other reasons, the incidence of strokes there is much higher than the rest of the country. First Responder takes to the skies Alongside the Emu study, Emvision expects First Responder pre-hospital studies to get underway with the Royal Flying Doctor Service (RFDS), a Melbourne MSU and a standard road ambo. 'The initial focus is on feasibility, usability and how it fits into the workflow,' Kirkland says. 'In parallel, we are doing product development translation from advanced prototypes to commercial production units.' To date, RFDS scanning of healthy volunteers in real-world conditions has confirmed First Responder's durability. The company is obtaining ethics approval to scan actual RFDS patients. A cost-effective solution In theory, Emu and First Responder should walk off the shelves, given the age-old problem they promise to solve. But for cash-strapped healthcare systems, cost is always a factor. Kirkland expects an Emu to cost around $US175,000 – about a third of the price of a decent CT machine. First Responder is likely to be half or a third of the cost of an Emu. The company also expects to charge US$25 per Emu scan and US$50 per First Responder scan for a 'consumable'. This single-use item is a liquid that flows through a silicon membrane used to adjust to varying head sizes. 'We think we have a compelling, cost-effective solution,' Kirkland says. Kirkland says chasing grants requires patience as the process winds from initial application to presentations, due diligence and contract negotiations. 'I won't give away too many secrets because there are still a lot of grants we want to apply for."
